Resolutions of Remedy Entertainment Plc's Annual General MeetingandtheorganizingmeetingoftheBoardofDirectors
The Annual General Meeting of
The Annual General Meeting adopted the Financial Statements for 2023, discharged the members of the Board of Directors and the CEO from liability, adopted the company's Remuneration Report and approved all proposals made to the Annual General Meeting in the form included in the notice to the Annual General Meeting.
Resolution on the use of the profit shown on balance sheet and dividend distribution
The Annual General Meeting resolved that no dividends shall be distributed for the financial period ended on
Composition and remuneration of the Board of Directors
The Annual General Meeting resolved that the number of Board members shall be five. Markus Mäki,
The Annual General Meeting resolved that the remuneration of the Board of Directors will remain unchanged. The Chairman of the Board of Directors is paid
Election and remuneration of the Auditor
The Annual General Meeting resolved to re-elect audit firm
The Annual General Meeting resolved that the Auditor's fees will be paid against the Auditor's reasonable invoice to be approved by the company.
Authorising the Board of Directors to resolve on the repurchase of own shares
The Annual General Meeting granted the Board of Directors an authorisation to resolve on the repurchase of
By virtue of the authorisation, the Board of Directors can resolve on the repurchase of a total maximum of 700,000 treasury shares by using the company's non-restricted equity. The proposed maximum number of shares that can be repurchased equals to approximately 5.20 percent of the company's all shares at the publication date of this release.
The authorisation is valid until the close of the company's following Annual General Meeting, but no longer than 18 months from the date of the Annual General Meeting's resolution. The authorisation replaces the share repurchase authorisation given to the Board of Directors by the company's Annual General Meeting held on
Authorising the Board of Directors to resolve on the issuances of shares and special rights to shares
The Annual General Meeting granted the Board of Directors an authorisation to resolve on the issuance of new shares, treasury shares and special rights to shares in one or several instalments with the following terms:
By virtue of the authorisation, the Board of Directors can resolve on the issuance of a maximum total of 700,000 new shares or treasury shares held by the company either against payment or without payment. The proposed maximum number of shares equals to approximately 5.20 percent of the company's all shares at the publication date of this release. The Board of Directors is also entitled to resolve on the issuance of option rights and other special rights to shares referred to in Chapter 10, Section 1 of the Finnish Companies Act either against payment or without payment within the maximum number of shares referred to above.
The new shares, treasury shares held by the company and special rights to shares may also be issued in deviation from shareholders' pre-emptive subscription right in a directed issuance if there is a weighty financial reason for doing so from the company's point of view. The Board of Directors has the authority to decide on all other matters pertaining to the issuances of shares and special rights to shares.
The authorisation is valid until the close of the company's following Annual General Meeting, but no longer than 18 months from the date of the Annual General Meeting's resolution. The authorisation replaces the previous authorisation to resolve on the issuance of shares and special rights entitling to shares which was given to the Board of Directors by the company's Annual General Meeting held on
Minutes of the Annual General Meeting
The Annual General Meeting minutes will be available at the latest by
Organizing meeting of the Board of Directors
At its organizing meeting held after the Annual General Meeting, the Board of Directors elected Markus Mäki to continue as the Chairman of the Board of Directors.
More information
Phone: +358504334992
Email: liisa.eloranta@remedygames.com
About Remedy
www.remedygames.com
https://news.cision.com/remedy-entertainment-oyj/r/remedy-entertainment-plc--resolutions-of-remedy-entertainment-plc-s-annual-general-meeting-and-the-o,c3960942
(c) 2024 Cision. All rights reserved., source